Propolis from two stingless-bee species is profiled and screened against viral and cancer models to guide prototype products. Laboratory potency is only a starting point; geographic variation, active constituents, normal-tissue toxicity and dosing need further study.
Key findings
- Propolis from two stingless-bee species is profiled and screened against viral and cancer models to guide prototype products. Laboratory potency is only a starting point; geographic variation, active constituents, normal-tissue toxicity and dosing need further study.
Why this matters globally
This work adds internationally comparable evidence in Health sciences and defines questions for replication in other populations or systems. Its global value lies in the evidence and transferable reasoning, not in a single impact score.
Thai researcher contribution
Thailand-linked authors and Kasetsart University, Khon Kaen University contribute to the research network behind this work. Thai participation is identified from bibliographic affiliations and should be checked against the author list and source article.
Limitations to consider
Controlled experiments do not establish in-vivo safety, clinical effectiveness, durability or industrial economics.
Verify the original sources
International Journal of Molecular SciencesRead the original article↗DOI: 10.3390/ijms27093855